logo
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection
Gene transfer of anti-gp41 antibody and CD4 immunoadhesin strongly reduces the HIV-1 load in humanized severe combined immunodeficient mice
Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users
Slower decline of plasma HIV-1 RNA following highly suppressive antiretroviral therapy in primary compared with chronic infection
Early brain injury in the SIV–macaque model of AIDS
Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients
Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection
Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection
Combination antiretroviral therapy and duration of pregnancy
Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen
Non-Hodgkin lymphoma in Uganda: a case–control study
Envelope V3 amino acid sequence predicts HIV-1 phenotype (co-receptor usage and tropism for macrophages)
A cell line-based bioassay of non β-chemokine-related HIV suppressive activity
Repeated and spontaneous switching of the chemokine co-receptors used by HIV-1 is rare in vivo
Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs
Discontinuation of secondary anti-Leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy
Highly active antiretroviral therapy decreases the incidence of visceral leishmaniasis in HIV-infected individuals
Spread of HIV infection in the general population in Germany
Sexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000
HIV prevalence and incidence among male-to-female transsexuals receiving HIV prevention services in Los Angeles County
ERRATUM